Total Payments
$16,514
2024 Payments
$2,005
Companies
60
Transactions
1,056
Medicare Patients
11,215
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$16,421 (99.4%)
Education$93.21 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,421 | 1,047 | 99.4% |
| Education | $93.21 | 9 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,974 | 104 | $0 (2024) |
| Novo Nordisk Inc | $1,417 | 109 | $0 (2024) |
| PFIZER INC. | $1,367 | 101 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,250 | 87 | $0 (2024) |
| Lilly USA, LLC | $1,048 | 80 | $0 (2023) |
| GlaxoSmithKline, LLC. | $755.49 | 46 | $0 (2024) |
| ABBVIE INC. | $727.56 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $648.23 | 44 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $550.50 | 29 | $0 (2022) |
| Merck Sharp & Dohme LLC | $508.28 | 42 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,005 | 103 | Phathom Pharmaceuticals, Inc. ($281.34) |
| 2023 | $1,467 | 76 | AbbVie Inc. ($176.49) |
| 2022 | $2,416 | 137 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($335.14) |
| 2021 | $2,025 | 125 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($331.53) |
| 2020 | $2,507 | 154 | AstraZeneca Pharmaceuticals LP ($471.71) |
| 2019 | $2,146 | 153 | AstraZeneca Pharmaceuticals LP ($384.83) |
| 2018 | $2,158 | 170 | Novo Nordisk Inc ($431.88) |
| 2017 | $1,790 | 138 | AstraZeneca Pharmaceuticals LP ($306.14) |
All Payment Transactions
1,056 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $118.44 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: PAIN | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.25 | General |
| 11/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CNS | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,314 | 5,246 | $901,484 | $336,298 |
| 2022 | 42 | 3,285 | 6,540 | $1.0M | $414,032 |
| 2021 | 37 | 2,964 | 6,585 | $873,355 | $438,598 |
| 2020 | 27 | 2,652 | 5,939 | $855,823 | $371,980 |
Total Patients
11,215
Total Services
24,310
Medicare Billing
$1.6M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 448 | 1,503 | $453,454 | $142,585 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 403 | 1,259 | $191,513 | $82,985 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 71 | 205 | $84,241 | $29,448 | 35.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 181 | 761 | $28,553 | $12,922 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $14,664 | $10,574 | 72.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 47 | 47 | $13,019 | $8,006 | 61.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 95 | 101 | $12,120 | $7,651 | 63.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $18,450 | $6,640 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 140 | 154 | $6,055 | $5,005 | 82.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $5,918 | $3,820 | 64.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 83 | $6,640 | $3,760 | 56.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 22 | $5,830 | $3,711 | 63.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 27 | 27 | $5,400 | $3,469 | 64.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 37 | $7,178 | $2,282 | 31.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 87 | 87 | $2,523 | $1,702 | 67.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 41 | 47 | $7,050 | $1,627 | 23.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 54 | 103 | $5,459 | $1,601 | 29.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 23 | $3,427 | $1,351 | 39.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 30 | 30 | $2,250 | $1,300 | 57.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 107 | $4,494 | $1,239 | 27.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 27 | 27 | $1,620 | $1,170 | 72.2% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 24 | 29 | $1,740 | $837.23 | 48.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 56 | 61 | $3,111 | $686.56 | 22.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 29 | 30 | $1,500 | $657.00 | 43.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 12 | $1,380 | $451.41 | 32.7% |
About Deepak Seth
Deepak Seth is a Specialist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154396711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deepak Seth has received a total of $16,514 in payments from pharmaceutical and medical device companies, with $2,005 received in 2024. These payments were reported across 1,056 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($16,421).
As a Medicare-enrolled provider, Seth has provided services to 11,215 Medicare beneficiaries, totaling 24,310 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Baltimore, MD
- Active Since 02/17/2006
- Last Updated 09/11/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154396711
Products in Payments
- XIFAXAN (Drug) $1,311
- FARXIGA (Drug) $889.61
- CHANTIX (Drug) $726.86
- VRAYLAR (Drug) $694.57
- JARDIANCE (Drug) $631.64
- Ozempic (Drug) $515.26
- TRULICITY (Drug) $493.03
- TRELEGY ELLIPTA (Drug) $461.39
- REXULTI (Drug) $451.77
- XARELTO (Drug) $436.69
- Zubsolv (Drug) $375.50
- SOLIQUA 100/33 (Biological) $374.99
- UBRELVY (Drug) $358.01
- Victoza (Drug) $329.16
- BEVESPI AEROSPHERE (Drug) $312.49
- Kerendia (Drug) $309.05
- Otezla (Drug) $292.56
- VOQUEZNA (Drug) $281.34
- Trintellix (Drug) $274.95
- SYMBICORT (Drug) $267.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Baltimore
Mr. James Gammie, M.d, M.D
Specialist — Payments: $29.8M
Specialist $29.8M
Dr. Richard Adler, M.d, M.D
Specialist — Payments: $3.1M
Specialist $3.1M
Dr. Philip Levin, M.d, M.D
Specialist — Payments: $921,481
Specialist $921,481
Dr. Agha Khan, Md, MD
Specialist — Payments: $170,581
Specialist $170,581
W. Eglseder, M.d, M.D
Specialist — Payments: $57,679
Specialist $57,679
Bartley Griffith, M.d, M.D
Specialist — Payments: $49,695
Specialist $49,695